Literature DB >> 26952590

Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measures.

Raina D Pang1, Matthew G Kirkpatrick2, Nicholas I Goldenson2, Casey R Guillot2, Adam M Leventhal3.   

Abstract

OBJECTIVE: Identifying factors that moderate subjective response to stimulants is important for understanding individuals at risk for abusing these drugs. Some research suggests that Asians may respond differently to stimulants than other races, but controlled human laboratory research of stimulant administration effects in Asians is scant.
METHODS: In this double-blind counterbalanced within-subject study, healthy stimulant-naïve participants (N = 65; 55% Asian; 63% female; age 18-35) received a single dose of 20-mg oral d-amphetamine or placebo on separate days. At each testing day, subjective measures of abuse liability and cardiovascular assessments were administered at repeated intervals before and after drug administration over a 4-hour period.
RESULTS: Asians (vs. Whites) demonstrated greater d-amphetamine-induced increases in diastolic blood pressure and ratings of 'Feel High' and 'Like Drug'.
CONCLUSIONS: Asian and White healthy young adults may differ in certain subjective and cardiovascular responses to acute doses of d-amphetamine. Such individual differences could help explain between-person differences in abuse potential of d-amphetamine and other stimulants.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asian; d-amphetamine; drug response; race

Mesh:

Substances:

Year:  2016        PMID: 26952590      PMCID: PMC4821659          DOI: 10.1016/j.pbb.2016.03.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  19 in total

1.  Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers.

Authors:  Matthew G Kirkpatrick; Nicholas I Goldenson; Nahel Kapadia; Christopher W Kahler; Harriet de Wit; Robert M Swift; John E McGeary; Steve Sussman; Adam M Leventhal
Journal:  Psychopharmacology (Berl)       Date:  2015-10-02       Impact factor: 4.530

2.  Nonmedical stimulant use among young Asian-Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals aged 12-34 years in the United States.

Authors:  Li-Tzy Wu; Marvin S Swartz; Kathleen T Brady; Dan G Blazer; Rick H Hoyle
Journal:  J Psychiatr Res       Date:  2014-09-16       Impact factor: 4.791

3.  The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010.

Authors:  Louisa Degenhardt; Amanda J Baxter; Yong Yi Lee; Wayne Hall; Grant E Sara; Nicole Johns; Abraham Flaxman; Harvey A Whiteford; Theo Vos
Journal:  Drug Alcohol Depend       Date:  2014-01-27       Impact factor: 4.492

4.  The drug effects questionnaire: psychometric support across three drug types.

Authors:  Meghan E Morean; Harriet de Wit; Andrea C King; Mehmet Sofuoglu; Sandra Y Rueger; Stephanie S O'Malley
Journal:  Psychopharmacology (Berl)       Date:  2012-12-28       Impact factor: 4.530

5.  Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women.

Authors:  A J Justice; H De Wit
Journal:  Pharmacol Biochem Behav       Date:  2000-07       Impact factor: 3.533

Review 6.  Do initial responses to drugs predict future use or abuse?

Authors:  Harriet de Wit; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2012-04-21       Impact factor: 8.989

7.  Increased methylphenidate usage for attention deficit disorder in the 1990s.

Authors:  D J Safer; J M Zito; E M Fine
Journal:  Pediatrics       Date:  1996-12       Impact factor: 7.124

8.  Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications.

Authors:  Jennifer Setlik; G Randall Bond; Mona Ho
Journal:  Pediatrics       Date:  2009-08-24       Impact factor: 7.124

9.  Drug preference and mood in humans: d-amphetamine.

Authors:  C E Johanson; E H Uhlenhuth
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?

Authors:  Rafael de la Torre; Samanta Yubero-Lahoz; Ricardo Pardo-Lozano; Magí Farré
Journal:  Front Genet       Date:  2012-11-12       Impact factor: 4.599

View more
  1 in total

1.  Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults.

Authors:  Adam M Leventhal; Matthew G Kirkpatrick; Mollie S Pester; John E McGeary; Robert M Swift; Steve Sussman; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2016-10-22       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.